Technical Analysis for CMTA - Clementia Pharmaceuticals Inc.
|Grade||Last Price||% Change||Price Change|
CMTA closed down 3.63 percent on Friday, December 14, 2018, on 27 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
|Weak or Absent||Down||Down||Down|
|See historical CMTA trend table...|
|Date||Alert Name||Type||% Chg|
|Dec 14||Wide Bands||Range Expansion||0.00%|
|Dec 14||Oversold Stochastic||Weakness||0.00%|
|Dec 13||Narrow Range Bar||Range Contraction||-3.63%|
|Dec 13||NR7||Range Contraction||-3.63%|
|Dec 13||Wide Bands||Range Expansion||-3.63%|
|Dec 13||Oversold Stochastic||Weakness||-3.63%|
|Dec 12||50 DMA Resistance||Bearish||-3.55%|
|Dec 12||Lower Bollinger Band Walk||Weakness||-3.55%|
|Dec 12||Wide Bands||Range Expansion||-3.55%|
|Dec 12||Oversold Stochastic||Weakness||-3.55%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. Its lead product candidate, palovarotene, is an oral small molecule that binds and activates retinoic acid receptor gamma (an RARg agonist), and has activity in preventing abnormal new bone formation as well as scar tissue formation (or fibrosis) in a variety of tissues in animal models. It is developing palovarotene for the treatment of Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma (MO). Its programs focus on diseases involving tissue transformation via retinoic acid receptors (RARs). The Company also has an eye drop formulation of palovarotene that can potently increase tear production and decrease corneal damage.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more CMTA news...
|52 Week High||20.15|
|52 Week Low||8.1|
|200-Day Moving Average||13.5706|
|50-Day Moving Average||12.6463|
|20-Day Moving Average||13.686|
|10-Day Moving Average||12.485|
|Average True Range||1.1388|
|Chandelier Exit (Long, 3 ATRs )||13.0836|
|Chandelier Exit (Short, 3 ATRs )||14.8164|
|Upper Bollinger Band||16.5264|
|Lower Bollinger Band||10.8456|
|Percent B (%b)||0.1|
|MACD Signal Line||-0.0694|
|Market Cap||348.01 Million|
|Num Shares||30.5 Million|
|Price-to-Earnings (P/E) Ratio||-0.02|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||12.33|
|Resistance 3 (R3)||12.43||12.23||12.18|
|Resistance 2 (R2)||12.23||11.99||12.18||12.12|
|Resistance 1 (R1)||11.81||11.84||11.71||11.71||12.07|
|Support 1 (S1)||11.19||11.37||11.09||11.09||10.73|
|Support 2 (S2)||10.99||11.22||10.94||10.68|
|Support 3 (S3)||10.57||10.99||10.63|
|Support 4 (S4)||10.47|